Author:
Wylie Annika,Jones Amanda E.,D'Brot Alejandro,Lu Wan-Jin,Kurtz Paula,Moran John V.,Rakheja Dinesh,Chen Kenneth S.,Hammer Robert E.,Comerford Sarah A.,Amatruda James F.,Abrams John M.
Abstract
Throughout the animal kingdom, p53 genes govern stress response networks by specifying adaptive transcriptional responses. The human member of this gene family is mutated in most cancers, but precisely how p53 functions to mediate tumor suppression is not well understood. Using Drosophila and zebrafish models, we show that p53 restricts retrotransposon activity and genetically interacts with components of the piRNA (piwi-interacting RNA) pathway. Furthermore, transposon eruptions occurring in the p53− germline were incited by meiotic recombination, and transcripts produced from these mobile elements accumulated in the germ plasm. In gene complementation studies, normal human p53 alleles suppressed transposons, but mutant p53 alleles from cancer patients could not. Consistent with these observations, we also found patterns of unrestrained retrotransposons in p53-driven mouse and human cancers. Furthermore, p53 status correlated with repressive chromatin marks in the 5′ sequence of a synthetic LINE-1 element. Together, these observations indicate that ancestral functions of p53 operate through conserved mechanisms to contain retrotransposons. Since human p53 mutants are disabled for this activity, our findings raise the possibility that p53 mitigates oncogenic disease in part by restricting transposon mobility.
Funder
National Research Service
National Institutes of Health
Welch Foundation I-1865
Ellison Medical Foundation
Children's Medical Center Foundation
Young Investigator Research Grant
Cancer Prevention and Research Institute of Texas
Damon Runyon Cancer Research Foundation
Publisher
Cold Spring Harbor Laboratory
Subject
Developmental Biology,Genetics
Cited by
172 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献